Leerink Partners

The Leerink Center for Pharmacoeconomics released its first newsletter today! “Diary of a Health Economist” will be coming out weekly and will discuss drug pricing, the importance of preserving the research and development ecosystem, and recent research related to health economics. This week’s newsletter included a real-world example of a launch price versus a generic price 11 years later. You will have to read the newsletter to find out what drug we are talking about. If you didn’t receive our newsletter this week, it’s easy to get on our email list. Visit https://lnkd.in/gpVjMp5n The Leerink Center for Pharmacoeconomics is a division of MEDACorp which is an affiliate of Leerink Partners. 

We are pleased to serve as sole bookrunner for Eledon Pharmaceuticals’ $85 Million Follow-On Offering. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw

We are excited to announce the expansion of our Healthcare Medical Technology, Life Science Tools and Diagnostics Investment Banking team with the appointments of Dr. Bernhard Sakmann and Justin Reed. Click here to view the full press release: https://lnkd.in/eg-Jz8UD

We are pleased to serve as lead placement agent for enGene’s $60 Million Private Placement. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw

We are pleased to serve as lead-left bookrunner for Molecular Partners’ $20 Million Follow-On Offering. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw

Melanie Whittington, Managing Director, and Head of the Center for Pharmacoeconomics, MEDACorp, will be a panelist at a special symposium “Celebrating Cost-Effectiveness Analysis” this Saturday, October 26th in Boston, MA. She will join leaders at the forefront of methods development to discuss new methods that will shape the future of value assessment. Learn more and register here: https://lnkd.in/eYmWsBHu   The Leerink Center for Pharmacoeconomics is a division of MEDACorp and an affiliate of Leerink Partners.

We are pleased to serve as exclusive financial advisor for Ocuphire Pharma, Inc. on its Acquisition of Opus Genetics, Inc. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw

We are excited to announce the launch of the Center for Pharmacoeconomics, a division of MEDACorp, as well as the appointment of Dr. Melanie Whittington as head of the Center. Click here to read the full press release: https://lnkd.in/eZNWgP9s MEDACorp LLC, an affiliate of Leerink Partners, is a global network of independent healthcare professionals (Key Opinion Leaders and consultants) providing industry and market insights to Leerink Partners and its clients.

Exciting to see our Senior Managing Director, Michael Cherny, featured in #Barrons, offering valuable insights into how Walgreens' store closures could impact the future of its stock. Barrons: https://lnkd.in/e8FH9K2a

We are pleased to serve as lead placement agent for OnKure Therapeutics’ $65 Million Private Placement in Connection with its Merger with Reneo Pharmaceuticals. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw